Source: Annual Congress 2010 - Tuberculosis drug resistance
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
S. M. A. Mamun, M. D. A. Islam (Dhaka, Bangladesh). Outcome of zinc & vit-A supplementation in the treatment multidrug resistance pulmonary tuberculosis patients. Eur Respir J 2010; 36: Suppl. 54, 4967

Member's Comments

No comment yet.

Related content which might interest you: The emerging problem of treating pulmonary M. avium complex (MAC) disease – microbial substitution of MAC to M. abscessus, Scedosporium and Nocardia after multi-drug chemotherapy in pulmonary MAC disease Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009 Outcome of vitamin A & zinc supplementation in the treatment of smear positive pulmonary tuberculosis patients Source: Annual Congress 2007 - Clinical tuberculosis Year: 2007 Predictors of PAO2 and PaCO2 in COPD patients Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases Year: 2009 Radiological findings and isolation days of pulmonary tuberculosis patients – comparison between active smokers and non-smokers/former-smokers Source: Annual Congress 2009 - Tobacco, bronchial tubes and the lung Year: 2009 Surgical treatment of pulmonary sequestration – 15-years experience Source: Annual Congress 2010 - Congenital lesions and rare pathology Year: 2010 Pulmonary tuberculosis – Still a challenging diagnosis Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011 Treatment of sarcoidosis – pentoxifylline Source: Annual Congress 2009 - Pleural and parenchymal diseases Year: 2009 Smoking assessment & treatment in hospital: Are we providing ‘right care‘ and/or missing cannabis-smoking? Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment Year: 2011 Vitamin D deficiency and outcome of tuberculosis therapy – A retrospective cohort study Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010 Evaluation of pulmonary diffusion: TLCO or KCO? Source: Annual Congress 2010 - Advances in lung function I Year: 2010 Tuberculosis in patients receiving anti-TNF-α treatment Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis Year: 2009 Destroyed lung secondary to tuberculosis – Surgical options Source: Annual Congress 2012 - Surgery for infections and congenital diseases Year: 2012 Evaluation of the effect of Category I anti tuberculous therapy on the vitamin D status of pulmonary tuberculosis patients Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019 Clinical outcomes of pulmonary arterial hypertension in carriers of ACVRL1 (ALK1) mutation Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension Year: 2009 Interrelation between mTB multi drug-resistance and cytokine activity in pulmonary TB patients and mTB virulence Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 Pulmonary tuberculosis presentation – Late diagnosis, advanced disease Source: Annual Congress 2012 - Tuberculosis: clinical findings III Year: 2012 Post-menopausal mammary tuberculosis – Report of three cases Source: Annual Congress 2011 - Management of tuberculosis Year: 2011 Cryptogenic organising pneumonia – clarithromycin treatment – factors influencing treatment results and relapses Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease Year: 2009 Drug interaction in tuberculosis treatment – The role of pharmacists Source: Annual Congress 2012 - Tuberculosis: clinical findings II Year: 2012